Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312]
Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache
Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus
Trepoxen-250
Nu-naprox Tab 125mg
Naproxen-375
Apo-napro-NA
All Day Sinus and Cold D
Leader Sinus and Cold-D
Naprosyn Sup 500mg
Naproxen Caplets
Pain Reliever
Sinus and Cold D
Teva-naproxen EC
Vicks Sinex D Severe Sinus and Cold
Naproxen Kit
Naprosyn E Tab 500mg
Naproxen sodium
Waymade-naproxen Sodium DS
PREVACID NapraPAC 250
Anaprox DS
Ntp-naproxen EC
Aleve-D Sinus and Headache
Foster and Thrive All Day Pain Relief
Sound Body Naproxen Sodium
Pain Relief All Day
Sunmark All Day Relief
Up and Up Sinus and Cold D
Up and Up Naproxen Sodium
Naproxen Sodium All Day Pain Relief
Rx Act Naproxen Sodium
Pediapharm Naproxen Suspension
Equate Naproxen Sodium
Indication
Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682